DAXXIFY Treatment

Schweiger Dermatology Group is now proud to offer DAXXIFY – the only long-lasting, peptide-powered frown line treatment. Patients exploring new injectable options may also be interested in learning about top cosmetic treatments and why natural-looking injectables continue to grow in popularity.

What is DAXXIFY and how is it different?

Conventional wrinkle-relaxing injectables last 3 – 4 months, with most patients coming back to the office four times a year to maintain results. With DAXXIFY you can keep your frown lines smoother for a full year with as few as 2 treatments.*

DAXXIFY is FDA approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some.* Patients comparing injectable treatments may also find it helpful to review fillers vs. Botox and understand what age to start Botox or similar wrinkle-relaxing treatments.

*At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.

Why are peptides important?

All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. DAXXIFY is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.

Is DAXXIFY well studied?

DAXXIFY was studied in the largest-ever clinical study conducted for a frown line treatment and included more than 2,400 people across different ages and skin types. Patients thinking about long-term wrinkle prevention may also want to explore preventative Botox and how other injectable options, including dermal fillers, may complement their treatment plan.

  • There were no serious treatment-related side effects in clinical trials for DAXXIFY
  • The active ingredient in DAXXIFY is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years =
  • 96% of people treated with DAXXIFY were satisfied with their results†

†96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies.

DAXXIFY Treatment at Schweiger Dermatology Group

Schweiger Dermatology Group offers DAXXIFY at various locations in NY, NJ, PA, CT, FL, IL, MN, MO and CA. Call us at (844) DERM-DOC to check availability at a location near you.

To find a location near you, check out our location pages. We look forward to working together to find the best treatment for your skin.

About Schweiger

We believe no one should wait to feel comfortable in their own skin. That's why we're committed to delivering The Ultimate Patient Experience—expert care that's fast, compassionate, and seamless. Founded by Dr. Eric Schweiger in 2010 to eliminate long wait times for high quality dermatologists, we've grown into one of the nation's leading dermatology practice, with hundreds of locations across the country and millions of satisfied patients. We offer medical, cosmetic, and surgical dermatology, as well as allergy services through Schweiger Allergy. Built around the needs of patients, Schweiger is committed to delivering high-quality, personalized care while removing barriers to access. With a focus on convenience, timely appointments, and clinical excellence, the practice makes expert skin and allergy care easier to get—often within days, with same- and next-day appointments available.